— Compensation report — Compensation of the Executive Committee for 2021
Compensation of the Executive Committee for 2021
Note: Mandatory compensation disclosure took effect as per the first day of trading of medmix shares on September 30, 2021. For maximum transparency, medmix opted to disclose compensation paid as of the spin-off date of September 20, 2021.
In 2021, the Executive Committee received a total compensation of kCHF 739, all of which was in cash; kCHF 144 was in pension and social security contributions, and kCHF 6 was in other payments.
The following table discloses the actual compensation paid to the members of the Executive Committee for financial year 2021 while performing services for medmix.
|
thousands of CHF |
|
2021 |
||||||||||||
|
|
Cash compensation |
|
Deferred compensation based on future performance |
|||||||||||
|
|
Base salary |
|
Bonus 2) |
|
Other 3) |
|
Pension and social security contributions 4) |
|
Total cash-based compen- sation |
|
Estimated value of share-based grant under the Perfor- mance Share Plan (PSP) 5) |
|
Total (incl. conditional share-based grant) |
|
|
thereof highest single compensation G. Cimermans, CEO |
|
154 |
|
163 |
|
5 |
|
73 |
|
395 |
|
0 |
|
395 |
|
Total Executive Committee 1) |
|
335 |
|
254 |
|
6 |
|
144 |
|
739 |
|
0 |
|
739 |
1) The total Executive Committee compensation for 2021 includes the compensation of Girts Cimermans, CEO since September 20, 2021; Jennifer Dean, CFO since September 20 , 2021; Friedrich von Gadow, Chief Human Resources Officer between September 20, 2021 and November 30, 2021; Itee Satpathy, Chief Human Resources Officer since December 01, 2021.
2) Expected bonus for the performance years 2021, to be paid out in the following year (accrual principle).
3) Other consists of child and insurance allowances.
4) Includes the employer contribution to social security.
5) First regular medmix grant to take place in 2022 only.
The total compensation of kCHF 739 awarded to the members of the Executive Committee for the financial year 2021 is within the maximum aggregate compensation amount of kCHF 750 that was approved by the shareholders at the 2021 EGM for the period commencing on September 20, 2021 and ending on December 31, 2021.
No severance payments to members of the Executive Committee were made during the reporting year.
As of December 31, 2021, there were no outstanding loans or credits granted to the members of the Executive Committee or former members of the Executive Committee.
In 2021, no compensation was granted to former members of the Executive Committee or related parties.